Our Team

Amy Bohnert, PhD, MHS

Principal Investigator

The Center for Clinical Management Research, Department of Veterans Affairs, University of Michigan Department of Anesthesiology

Sheba Sethi, MD

MOC Lead Physician

Areas of interest: Integrating MOUD in primary care, polysubstance use

Lewei Allison Lin, MD, MS

MOC Consulting Physician

University of Michigan Department of Psychiatry, University of Michigan Addiction Center, Ann Arbor Veterans Affairs Health System

Chris Frank, MD, PhD

MOC Consulting Physician

Michigan Medicine Family Medicine; Areas of interest: Rural health, OB/GYN and SUD

Robert McMorrow, DO, FASM

MOC Consulting Physician

MidMichigan Community Health; Areas of interest: Polysubstance use and integrating MOUD in rural settings, Hepatitis C treatment

Jonathan Morrow, MD

MOC Consulting Physician

University of Michigan Department of Psychiatry, University of Michigan Addiction Center; Areas of interest: Psychiatric comorbidities

Cara Poland, MD, MEd, FACP, DRASAM

MOC Consulting Physician

Medical Director of Addiction Medicine, Michigan State University, GREAT MOMs Physician; Areas of interest: Women's health, primary care, polysubstance use, rural populations

Ponni Perumalswami, MD, MSCR

MOC Consulting Physician

Michigan Medicine Internal Medicine, Department of Gastroenterology and Hepatology, Ann Arbor Veterans Affairs Health System; Areas of interest: Expanding Hepatitis C Virus treatment capacity

Dan Berland, MD

MOC Consulting Physician

University of Michigan Department of Anesthesiology; Areas of interest: Pain, opioid tapers

Eliza Hutchinson, MD

MOC Consulting Physician

University of Michigan MAT Medical Director, Assistant Professor, Department of Family Medicine, Packard Health

Paul Trowbridge, MD

MOC Consulting Physician

Trinity Health West Michigan, Recovery Medicine; Associate Professor Michigan State University; Assistant Program Director Trinity Health/Michigan State University Addiction Medicine Fellowship; Areas of Interest: Infectious complications of substance use, expanding utilization of HIV prophylaxis and HCV treatment, expanding use of evidence-based treatments for substance use disorders in hospitalized patients, expanding rural access to evidence-based treatments for substance use disorders